Pediatrix Medical Group (NYSE:MD) Hits New 12-Month High – Should You Buy?

Pediatrix Medical Group, Inc. (NYSE:MD) shares reached a new 52-week high during trading on Monday . The company traded as high as $26.88 and last traded at $26.9450, with a volume of 780722 shares trading hands. The stock had previously closed at $26.76.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on MD. Mizuho set a $24.00 price objective on Pediatrix Medical Group in a report on Friday, May 8th. UBS Group boosted their target price on shares of Pediatrix Medical Group from $22.00 to $25.00 and gave the company a “neutral” rating in a report on Tuesday, May 12th. Jefferies Financial Group reiterated a “buy” rating and issued a $27.00 price target on shares of Pediatrix Medical Group in a research note on Monday, April 20th. Truist Financial lifted their price target on shares of Pediatrix Medical Group from $21.00 to $23.00 and gave the company a “hold” rating in a research report on Monday, April 13th. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Pediatrix Medical Group in a research note on Wednesday, June 24th. One equities research analyst has rated the stock with a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat.com, Pediatrix Medical Group presently has an average rating of “Hold” and an average target price of $22.50.

Pediatrix Medical Group Trading Down 1.9%

The stock’s 50 day moving average is $23.36 and its 200-day moving average is $21.95. The company has a market cap of $2.21 billion, a P/E ratio of 13.04 and a beta of 0.66. The company has a current ratio of 1.33, a quick ratio of 1.33 and a debt-to-equity ratio of 0.45.

Pediatrix Medical Group (NYSE:MD) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.44 earnings per share for the quarter, beating analysts’ consensus estimates of $0.37 by $0.07. The business had revenue of $476.20 million during the quarter, compared to analyst estimates of $465.83 million. Pediatrix Medical Group had a net margin of 9.02% and a return on equity of 19.94%. Pediatrix Medical Group’s revenue was up 3.9% compared to the same quarter last year. During the same period last year, the business earned $0.33 EPS. Research analysts anticipate that Pediatrix Medical Group, Inc. will post 2.1 earnings per share for the current fiscal year.

Insider Buying and Selling at Pediatrix Medical Group

In related news, Director Shirley A. Weis sold 36,028 shares of the business’s stock in a transaction that occurred on Wednesday, May 13th. The shares were sold at an average price of $23.75, for a total value of $855,665.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 1.80% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the business. Global Retirement Partners LLC boosted its position in shares of Pediatrix Medical Group by 68,250.0% during the fourth quarter. Global Retirement Partners LLC now owns 1,367 shares of the company’s stock valued at $29,000 after buying an additional 1,365 shares during the last quarter. Transamerica Financial Advisors LLC purchased a new position in Pediatrix Medical Group in the 4th quarter worth about $30,000. Eurizon Capital SGR S.p.A. bought a new position in Pediatrix Medical Group during the 4th quarter valued at about $33,000. Blue Trust Inc. purchased a new stake in shares of Pediatrix Medical Group during the 4th quarter valued at about $37,000. Finally, TD Private Client Wealth LLC purchased a new stake in shares of Pediatrix Medical Group during the 4th quarter valued at about $39,000. Hedge funds and other institutional investors own 97.71% of the company’s stock.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.